FDG PET for the study of primary hepatic malignancies in children

Pediatric Blood and Cancer

Volumn 47, Issue 1, 2006, Pages 51-55

  Mody, Rajen J ^a   Pohlen, Judith A ^a   Malde, Sachit ^b   Strouse, Peter J ^a   Shulkin, Barry L ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

FDG PET; Hepatoblastoma; Liver; Malignancy; Pediatric; Rhabdomyosarcoma

Indexed keywords

ALPHA FETOPROTEIN; FLUORODEOXYGLUCOSE;

ARTICLE; BRAIN BIOPSY; CANCER STAGING; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE MARKER; DRUG UPTAKE; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; GLYCOLYSIS; GRANULOMA; HEPATOBLASTOMA; HEPATOGRAPHY; HUMAN; IMAGE ANALYSIS; INFANT; LIVER CANCER; LIVER RESECTION; MALE; METASTASIS; NECROTIZING GRANULOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITATIVE ANALYSIS;

CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RHABDOMYOSARCOMA, EMBRYONAL; SENSITIVITY AND SPECIFICITY;

EID: 33646883545     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20524     Document Type: Article

References (8)

1. Maisey MN. Overview of clinical PET. Br J Radiol 2002; S1-S5.
2. Shulkin BL, Mitchell DS, Ungar DR, et al. Malignancy in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology 1995;194:495-500.
3. Shulkin BL. PET applications in pediatrics. Q J Nucl Med 1997; 41:281-291.
4. Herrera JM, Krebs A, Harris P, et al. Childhood tumors. Surg Clin North Am 2000;80:747-759.
5. Teefey SA, Hildeboldt CC, Dehdashti F, et al. Detection of hepatobiliary malignancy in liver transplant candidates: Prospective comparison of CT, MR imaging, US, and PET. Radiology 2003; 226:553-542.
6. Herzog CE, Andrassay RJ, Eftekhari F. Childhood cancers: Hepatoblastoma. The Oncologist 2000;5:445-453.
7. Wudel LJ, Delbeke D, Morris D, et al. The role of [18F] flurodeoxyglucose positron emission tomography in the evaluation of hepatocellular carcinoma. Am Surg 2003;69:117-124.
8. Anderson GS, Brinkmann F, Soulen MC, et al. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nuc Med 2003;28:192-197.